Shares of Aurobindo Pharma hit a two-year high of Rs 872.95, as they gained 4 per cent on the BSE in Monday’s intra-day trade after the company got US drug regulator’s approval for skin and bone infection drug. The stock was trading at its highest level since August 2021. Thus far in calendar year 2023,… Continue reading Aurobindo Pharma hits 2-year high; stock zooms 100% thus far in 2023